March 2014 FDA Recall Drug by Glenmark Generics Inc., Usa
D-1229-2014 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Glenmark Generics Inc., Usa on March 18, 2014 for the product Drug. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1229-2014

Reason for Recall
Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.
Initiated
03-18-2014
Reported
04-16-2014
Quantity
2904 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Glenmark Generics Inc., USA
Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals Limited, Unit-II R.S. No 32 33 & 34, Shasun Road, Periyakalapet, Puducherry, - 605 014, India; Manufactured for: Glenmark Generics Inc, USA, Mahwah, NJ 07430, UPC 3 68462 24805 8, NDC 68462-248-05.

Batch or Lot Expiration Information

Lot# Lot 12AN118A, Exp 10/14